Hepatocellular carcinoma (HCC) is a major global burden, ranking as the third leading cause of cancer-related mortality. HCC due to chronic hepatitis B virus (HBV) or C virus (HCV) infection has decreased due to universal vaccination for HBV and effective antiviral therapy for both HBV and HCV, but HCC related to metabolic dysfunction-associated steatotic liver disease and alcohol-associated liver disease is increasing. Biannual liver ultrasonography and serum α-fetoprotein are the primary surveillance tools for early HCC detection among high-risk patients (e.g., cirrhosis, chronic HBV). Alternative surveillance tools such as blood-based biomarker panels and abbreviated magnetic resonance imaging (MRI) are being investigated. Multiphasic computed tomography or MRI is the standard for HCC diagnosis, but histological confirmation should be considered, especially when inconclusive findings are seen on cross-sectional imaging. Staging and treatment decisions are complex and should be made in multidisciplinary settings, incorporating multiple factors including tumor burden, degree of liver dysfunction, patient performance status, available expertise, and patient preferences. Early-stage HCC is best treated with curative options such as resection, ablation, or transplantation. For intermediate-stage disease, locoregional therapies are primarily recommended although systemic therapies may be preferred for patients with large intrahepatic tumor burden. In advanced-stage disease, immune checkpoint inhibitor-based therapy is the preferred treatment regimen. In this review article, we discuss the recent global epidemiology, risk factors, and HCC care continuum encompassing surveillance, diagnosis, staging, and treatments.
Citations
Citations to this article as recorded by
Response Assessment in Hepatocellular Carcinoma: A Primer for Radiologists Nayla Mroueh, Jinjin Cao, Shravya Srinivas Rao, Soumyadeep Ghosh, Ok Kyu Song, Sasiprang Kongboonvijit, Anuradha Shenoy-Bhangle, Avinash Kambadakone Journal of Computer Assisted Tomography.2026; 50(2): 167. CrossRef
Emerging evidence supports direct-acting antiviral therapy for HCC patients beyond the early stage: Correspondence to editorial on “Direct-acting antiviral therapy for patients with HCV-related hepatocellular carcinoma: A nationwide cohort study” Teng-Yu Lee, Pei-Chien Tsai, Shou-Wu Lee, Ming-Lung Yu Clinical and Molecular Hepatology.2026; 32(1): e68. CrossRef
Advancing policy and practice in alcohol-associated liver disease and alcohol-attributable cancer: Correspondence to the editorial on “Sex disparities in alcohol-associated liver disease and subtype differences in alcohol-attributable cancers in the Unite Pojsakorn Danpanichkul, Donghee Kim, Karn Wijarnpreecha, Amit G. Singal, Ju Dong Yang Clinical and Molecular Hepatology.2026; 32(1): e96. CrossRef
Transarterial radioembolization versus atezolizumab-bevacizumab for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis Youngsu Park, Yuri Cho, Seung Up Kim, Aryoung Kim, Hyunjae Shin, Hyo-Cheol Kim, In Joon Lee, Gyoung Min Kim, Dongho Hyun, Yunmi Ko, Jeayeon Park, Jae Woong Yoon, Gyung Sun Lim, Moon Haeng Hur, Yun Bin Lee, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Diagnostic and Interventional Imaging.2026; 107(1): 25. CrossRef
The diagnostic value of 18 F-FAPI-04 PET/CT in unresectable hepatocellular carcinoma: a head-to-head comparison with 18 F-FDG PET/CT Huanyu Gong, Yong Cheng, Qiang Li, Yingjun He, Qijun Cai, Yongjin Tang, Yulong Liu, Lu Kuang, Yingxin Li, Jingjie Shang, Chengzhi Li, Kangshou Liu, Mingrong Cao, Lu Wang, Xueying Ling, Hao Xu European Journal of Nuclear Medicine and Molecular Imaging.2026; 53(3): 1700. CrossRef
Gender, Age, Alpha-fetoprotein, and Des-gamma-carboxyprothrombin Score as a Novel Approach to Early Detection of Hepatocellular Carcinoma: A Narrative Review Ludovico Abenavoli, Giuseppe G.M. Scarlata, Maria L. Gambardella, Ivo Lopez, Giuseppe Sena, Domenico Laganà, Francesco Luzza, Giuseppe Currò Journal of Clinical and Experimental Hepatology.2026; 16(1): 103203. CrossRef
MRI-based Habitat Imaging Enhances the Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma Xiaogang Li, Anbin Hu Academic Radiology.2026; 33(1): 59. CrossRef
Split biosensor based on nano-enzymatic ferrocene-tyramine deposition reaction for detection of SMP30 antibody Yanping Xing, Xixiang Xie, Jiangtao Liu, Tao Zhao, Xiyu Liu, Pan Wu, Faquan Lin, Yong Huang Analytica Chimica Acta.2026; 1382: 344834. CrossRef
Ferroptosis modulation by METTL14 in cancers: From molecular insights to therapeutic strategies Boran Huang, Chenglin Zhu, Xinyu Zhang, Qi Zhang, Honggang Wang Cellular Signalling.2026; 138: 112212. CrossRef
Integrated multi-Omics and network toxicology elucidate the multi-target mechanisms of environmental hormones in driving hepatocellular carcinoma Rong Huang, Jinyue Ma, Jiaxin Yao, Jiyu Pang, Min Zhang, Lu Wen, Liang Wang, Yanan Deng, Xiu He, Chunyan Zhao, Bo Mu Ecotoxicology and Environmental Safety.2026; 309: 119519. CrossRef
The regulatory role of circGDI2 in hepatocellular carcinoma proliferation and glycolysis with the involvement of m6A modification Shiyi Chen, Hongxiang Xia, Shuwei Chen Non-coding RNA Research.2026; 17: 21. CrossRef
CTTN overexpression on circulating tumor cells promotes hepatocellular carcinoma recurrence via enhancing the proliferation and clonality of circulating tumor cells Yongzhi Liu, Zhidong Fu, Lihui Jiang, Yang Chen, Feng Jiang, Chuanling Zhang, Tieming Zhu Cytotechnology.2026;[Epub] CrossRef
Intra-tumoral microbiota: Key modulators of tumor immunity and therapeutic potential Junju He, Hui Tan, Yanru Qiu, Yuchao Dan, Qian Wan, Lan Li, Jie Wu, Qibin Song, Hongbin Chen, Bin Xu Genes & Diseases.2026; 13(4): 101963. CrossRef
Phenylalanine-Coated PLGA Nanoparticles for Targeted Delivery of Silibinin in Hepatocellular Carcinoma Claudia Mari, Federica Aliperta, Amadeo Sanz-Pérez, Mario Alonso, Elena González-Burgos, Juan Francisco González, Irene Lozza, Ana Fernández-Carballido, Ana Isabel Fraguas-Sánchez Molecular Pharmaceutics.2026; 23(1): 487. CrossRef
Outcomes of Nivolumab Plus Ipilimumab After Atezolizumab Plus Bevacizumab in Advanced HCC: An International Multicentre Study Jung Sun Kim, Jeffrey Wong, San‐Chi Chen, David Tai, Hannah Yang, Youngun Kim, Beodeul Kang, Ilhwan Kim, Hyeyeong Kim, Chansik An, Su Jin Jang, Masatoshi Kudo, Ho Yeong Lim, Chan Kim, Thomas Yau, Hong Jae Chon Liver International.2026;[Epub] CrossRef
Integrative analyses of network pharmacology and bioinformatics reveal the synergistic antitumor effects of cantharidin and ginsenosides Rg3 on hepatocellular carcinoma Xianggang Gou, Zhongzheng Zhou, Yuehua Wang, Henye Yuan, Ziyao Wang, Jie Chen, Wei Yan, Haisheng Wang, Jia Yan Biochemical Pharmacology.2026; 246: 117700. CrossRef
Risk stratification for hepatocellular carcinoma in metabolic dysfunction-associated steatotic liver disease: Editorial on “High Steatosis-Associated Fibrosis Estimator scores predict hepatocellular carcinoma in viral and non-viral hepatitis and metabolic Ho Soo Chun, Minjong Lee Clinical and Molecular Hepatology.2026; 32(1): 368. CrossRef
An Inflammation-Associated Prognostic Model for Hepatocellular Carcinoma Following Radical Resection Yanyun Zhai, Biling Gan, Renguo Guan, Ye Lin, Yanxia Lu Journal of Hepatocellular Carcinoma.2026; Volume 13: 1. CrossRef
Distinct tumor immune microenvironment modulation by anti-PD-1/PD-L1, VEGF, and CTLA-4 blockade provides a rationale for triplet therapy in hepatocellular carcinoma Hideki Iwamoto, Hironori Koga, Takumi Kawaguchi Clinical and Molecular Hepatology.2026; 32(1): e38. CrossRef
Landscape of Somatic and Age‐Related Pathogenic Structural Variations in Hepatocellular Carcinoma Revealed by Long‐Read Sequencing Zhewen Wei, Yinghao Cao, Hongchao Liu, Mei Liu, Bolun Zhang, Jianming Ying, Jianqiang Cai, Xinyu Bi, Jianjun Zhao, Jianguo Zhou, Zhiyu Li, Zhen Huang, Jianmei Liu, Xueyan Lv, Zhiwen Luo, Zhicheng Wei, Xiaoshi Zhang, Yi Yang, Yiqiao Deng, Yanjiang Yin, Jin MedComm.2026;[Epub] CrossRef
Gastrointestinal cancer statistics in 2022 and projection to 2050: GLOBOCAN estimates across 185 countries Pojsakorn Danpanichkul, Yanfang Pang, Primrose Tothanarungroj, Disatorn Dejvajara, Donghee Kim, Preenapun Saokhieo, Kanokphong Suparan, Mark D. Muthiah, Kwanjit Duangsonk, Diego Olavarria Bernal, Rashid N. Lui, Karn Wijarnpreecha, Ghassan K. Abou‐Alfa, Mi Cancer.2026;[Epub] CrossRef
Integrating CyTOF with scRNA-seq reveals that Cyclovirobuxine D inhibits HCC progression through hepatic immune microenvironment remodeling Fuqiang Ma, Lele Zhang, Yitao Fan, Ziyi Xu, Yuhua He, Jiachun Sun, Juan Lu, Xinyu Gu Phytomedicine.2026; 150: 157751. CrossRef
A Biomimetic Manganese Complex Synergistically Disables Antioxidant Defenses and Amplifies Oxidative Stress to Potentiate Ferroptosis in Hepatocellular Carcinoma Pengchen Ren, Yan Huang, Linhong Zhong, Ranran Luo, Chenxi Zhang, Zening Zhang, Rui Tang, Zhongsheng Xu, Yun Liu Advanced Healthcare Materials.2026;[Epub] CrossRef
Effectiveness of Machine Learning in Detecting Vessels Encapsulating Tumor Clusters in Hepatocellular Carcinoma: Systematic Review and Meta-Analysis Huili Shui, Wenyu Wu, Zhenming Xie, Bing Yang, Jia Deng, Dongxin Tang Journal of Medical Internet Research.2026; 28: e82839. CrossRef
Stemness CD24 activation promotes hepatocellular carcinoma progression via an immune escape mechanism Yin Cai, Lu-Yin Liu, Xiao-Xiao Xia, Hao Tang, Min Xu, Wen-Li Sai, Deng-Fu Yao, Min Yao World Journal of Gastroenterology.2026;[Epub] CrossRef
Effect of statin use on prognostic outcomes in hepatocellular carcinoma following liver surgery: a systematic review and meta-analysis Diski Saisa, Syifa Mustika, Mochamad Fachrureza, Stevanus Christian Surya, Derren Rampengan, Juan Alessandro Jeremis Maruli Nura Lele, Ammar Nojaid, Michael Owen Hogipranata European Journal of Gastroenterology & Hepatology.2026; 38(5): 527. CrossRef
Identification of novel circulating protein biomarkers for hepatocellular carcinoma superior to alpha-fetoprotein through a stemness index and secretome analysis Cai Gao, Xuebing Li, Xinwei Liu, Sha Yan, Xiaodan Ran, Jingxian Han World Journal of Surgical Oncology.2026;[Epub] CrossRef
NOP56 interacts with Fibrarin to regulate the PI3K/AKT signaling pathway and inhibit apoptosis of hepatocellular carcinoma Hongwei Chen, Xinggang Fan, Di Cui Frontiers in Oncology.2026;[Epub] CrossRef
Unmet needs in hepatology: The guidance of the Italian association for the study of the liver (AISF) Stefano Gitto, Filippo Gabrielli, Giovanni Addolorato, Claudia Tarli, Giacomo Zaccherini, Rosaria Calia, Giacomo Germani, Patrizia Burra, Alberto Zanetto, Francesca Ferri, Roberta D’Ambrosio, Pierluigi Toniutto, Nicola Pugliese, Fiammetta Cosci, Giuseppe Digestive and Liver Disease.2026; 58(2): 182. CrossRef
Integrative multiomics dissection of LSM7 as a prognostic biomarker and therapeutic target in hepatocellular carcinoma Shanshan Fan, Yifeng He, Peifeng Ke, Jianhong Jiang, Shengming Zhang, Deqin Zeng, Juan Duan, Ming Wu Science Progress.2026;[Epub] CrossRef
AEG-1/MTDH Enhances Hepatocellular Carcinoma Radioresistance by Recruiting PTBP1 Via SND1 To Stabilize ATG5 mRNA and Promote Protective Autophagy Xiaochun Chen, Yu Wang, Qishuai Guo, Xing Lin, Zhiping Yuan, Wei Liu, Chuan Lin, Yongjun Li, Yongpeng He Cell Biochemistry and Biophysics.2026; 84(2): 2087. CrossRef
A prognostic signature of ferroptosis and lipid metabolism related genes predicts survival and immunotherapy response in hepatocellular carcinoma Hu Chen, Yan Kong, Qian Dong Discover Oncology.2026;[Epub] CrossRef
Emerging importance of ALDH2 in liver diseases and its potential therapeutic role Sheng Wang, Shiqiang Xu, Guoqing Xia, Xinren Wang, Xiongwen Lv Biochemical Pharmacology.2026; 246: 117732. CrossRef
Regulation of Keratin Chemical Modifications: Potential Molecular Mechanisms in Proliferative Diseases Xuemei Ma, Xiaoli Jiang, Mengxue Song, Bingbing Bai, Xia Hou, Qingtian Wu International Journal of Molecular Sciences.2026; 27(2): 972. CrossRef
Non-Transplantable Recurrence After Initial Liver Resection of Hepatocellular Carcinoma: A Narrative Review Dima Malkawi, Ioannis A. Ziogas, Ana L. Gleisner, Richard D. Schulick, Dimitrios P. Moris Cancers.2026; 18(2): 317. CrossRef
Postoperative adjuvant TACE combined with lenvatinib and immune checkpoint inhibitors for hepatocellular carcinoma with high recurrence risks: a multicenter retrospective study Ziyue Huang, Taifeng Zhu, Xiaokun Chen, Mingjian Piao, Yang Tan, Chengjie Li, Kai Liu, Shanshan Wang, Lei Zhang, Shunda Du, Chengpei Zhu, Kang Zhou, Xiaobo Yang, Daobing Zeng, Haitao Zhao BMC Cancer.2026;[Epub] CrossRef
SLC25A39 binds and modulates PRDX1 to suppress ROS-induced necroptosis in hepatocellular carcinoma Wenxuan Liu, Tianrui Kuang, Keshuai Dong, Man Li, Wenhong Deng, Jia Yu International Immunopharmacology.2026; 172: 116246. CrossRef
RNA splicing dysregulation in hepatocellular carcinoma: Molecular mechanisms, therapeutic targets, and intervention strategies—A comprehensive review Shuai Xiong, Lei Hu, Yun-Yang Sun, Wei Huang, Xiao-Yu Hu Biomedicine & Pharmacotherapy.2026; 195: 119025. CrossRef
Assessing predictive value of contrast-enhanced ultrasound combined with doppler ultrasound for post-transcatheter arterial chemoembolization prognosis in hepatocellular carcinoma Jia-Jiao Qian, Min Xu, Yan-Song Ji World Journal of Gastrointestinal Surgery.2026;[Epub] CrossRef
Adjuvant cytokine-induced killer cell immunotherapy in hepatocellular carcinoma: real-world data and 9-year extended follow-up of a randomized controlled trial Hyunjae Shin, Youngsu Park, Byeong Geun Song, Won-Mook Choi, Hyung Joon Han, Youngwoo Lee, Tae-Jin Song, Jong-Eun Yeon, Young-Suk Lim, Moon Haeng Hur, Yun Bin Lee, Eun Ju Cho, Su Jong Yu, Yoon Jun Kim, Joon Hyeok Lee, Jung-Hwan Yoon, Jeong-Hoon Lee Cancer Immunology, Immunotherapy.2026;[Epub] CrossRef
First-line systemic therapy for hepatocellular carcinoma: new options Rashida V. Orlova, Natalia V. Popova, Svetlana I. Kutukova, Viacheslav A. Chubenko, Rima S. Agbalyan, Michael V. Pugin Clinical Case in Oncology.2026; 3(3): 15. CrossRef
Chronic inflammation and immune response in hepatocellular carcinoma: a comprehensive literature review Manaf Alsudaney, Mohammed N. Abdulhaleem, Abdelrahman M. Attia, Jessica Liu, Hasmik Adetyan, Osama Khattab, Andrew Hendifar, Alexander Kuo Journal of Cancer Metastasis and Treatment.2026;[Epub] CrossRef
Preclinical Evaluation of Rationally Designed Peptide-NIRF Probe for c-Met Positive Liver Cancer Imaging-Guided Surgery Xiaohui Wang, Yongjia Tang, Mengmeng Xiao, Jia Huang, Yaxue Dai, Wenjing Huang, Zhihao Han, Yueqing Gu Analytical Chemistry.2026; 98(5): 4179. CrossRef
Research Progress on the Biological Function, Disease-Driving Mechanism and Clinical Targeting Strategies of G3BP2 Yao Chen, Qi Deng, Li-Ling Yang, Ai-Ling Jiang, Rong Zhang, Qi-Bing Yan, Yong-Kang Wu Molecules.2026; 31(4): 622. CrossRef
Quality of Gadoxetate-enhanced MRI versus US during Hepatocellular Carcinoma Screening in Participants with Cirrhosis Sara Lewis, Benjamin Wildman-Tobriner, Jordan Cuevas, Sergio Calle, Ian Bolger, Katherine Wang, Himanshu Joshi, Lori Mankowski Gettle, Ju Dong Yang, Ji Hye Min, Claude B. Sirlin, Scott B. Reeder, Mustafa R. Bashir, Bachir Taouli Radiology.2026;[Epub] CrossRef
KLF1 Exerts Pro‐Tumour Role in Liver Cancer via Inhibiting ACSL4/LPCAT3‐Regulated Ferroptosis Zhihui Chen, Changyan Zhang, Jialin Yang, Yong Peng Journal of Cellular and Molecular Medicine.2026;[Epub] CrossRef
Pretransplant Systemic Therapies for Hepatocellular Carcinoma: A Systematic Review of Posttransplant Outcomes Joana Rodrigues Ribeiro, Célia Procter, Christian Toso Journal of Gastrointestinal Cancer.2026;[Epub] CrossRef
Expert consensus on the selection of surgical treatment modalities for hepatocellular carcinoma (fourth revision) Xiaoping Chen Oncology and Translational Medicine.2026; 12(3): 117. CrossRef
Comparing Minimally Invasive Puncture Under Local Anesthesia to Open Laparotomy Under General Anesthesia for Establishing a Rabbit VX2 Liver Tumor Model Gang Yuan, Ran Cui, Yanneng Xu, Jianming Luo, Bo Zheng, Wei Hu, Xun Zhang, Guangyan Si Journal of Hepatocellular Carcinoma.2026; Volume 13: 1. CrossRef
Structure–function paradigms of natural polysaccharides in hepatocellular carcinoma therapy Jingqian Guan, Kexin Liang, Hongbo Su, Xizi Jiang Carbohydrate Polymers.2026; 380: 125093. CrossRef
Identification of Unrecognized Hepatitis B, C, and D Infections Through the Private Laboratory-Based RE-LINK Screening Project in Romania: A Micro-Elimination Initiative Liliana Gheorghe, Antoanela Curici, Speranta Iacob Livers.2026; 6(1): 13. CrossRef
FAM216A Promotes Hepatocellular Carcinoma Proliferation and Invasion through the PLK1/ERK Signaling Pathway Peng Ma, Ying Hao, Yuefeng Zhang, Weiguo Tang, Wei Wang, Zuo Muo, Kaihuan Yu, Weixing Wang Genetic Testing and Molecular Biomarkers.2026; 30(3): 55. CrossRef
Effect of compound kushen injection on immune function in patients with primary liver cancer: a systematic review and meta-analysis Yu Xiong, Yutong Cai, Chenxi Li, Qian Yan, Xiongwen Wang, Xiaoying Zhang Frontiers in Pharmacology.2026;[Epub] CrossRef
Achieving free-breathing liver magnetic resonance imaging by combining compressed sensing with the number of excitations Ruirui Yang, Huicong Shen, Boyun Yan, Zhaoying Liu, Yanan Dong, Jiawei Zhang, Wenjia Wang, Liu Ya jie Abdominal Radiology.2026;[Epub] CrossRef
GPC3 and CD133-targeted peptide dual modification enhances the therapeutic effect of doxorubicin carried by OMVs on hepatocellular carcinoma Zuo Mou, Yuefeng Zhang, Xiaodian He, Mingze Zhang, Xiaoqin He, Wei Wang, Zehao Liu, Xinxin Xiong, Peng Ma, Kaihuan Yu International Journal of Pharmaceutics: X.2026; 11: 100510. CrossRef
Synchronous vs sequential combination of transarterial chemoembolization and microwave ablation for hepatocellular carcinoma: Efficacy and prognosis Yi Yu, Wei Yuan, Jin Lei, Chun-Bo Zhao, Cheng-Gang Tao, Sheng-Hui Liu, Bai-Lin Wang World Journal of Gastrointestinal Surgery.2026;[Epub] CrossRef
When viruses recede and alcohol advances: demographic momentum and policy gaps in alcohol-associated liver cancer Yoon Jun Kim Hepatology International.2026; 20(2): 257. CrossRef
Accuracy of Medical Image–Based Deep Learning for Detecting Microvascular Invasion in Hepatocellular Carcinoma: Systematic Review and Meta-Analysis Wei Feng, Bo Qu, Shuo Han Journal of Medical Internet Research.2026; 28: e82000. CrossRef
Liver transplantation for hepatocellular carcinoma: from patient selection and downstaging to risk stratification and post-transplant surveillance Mohammad Saeid Rezaee-Zavareh, Ju Dong Yang Gastroenterology Report.2026;[Epub] CrossRef
Early recurrence prediction and risk stratification of hepatocellular carcinoma after transarterial chemoembolization achieving imaging complete response based on contrast-enhanced CT machine learning Luhao Liu, Yiyang Liu, Dongxi Lin, Ke Meng, Xiaoman Yang, Jiliang Zhou, Xinrui Ni, Chunlai Yu, Zhou Zhou Abdominal Radiology.2026;[Epub] CrossRef
Optimizing Screening of Hepatocellular Carcinoma with Computed Tomography and MR Imaging Julie Y. An, Bari R. Dane, Robert M. Marks Radiologic Clinics of North America.2026; 64(3): 475. CrossRef
Multi-omics biomarker detection in Diethylnitrosamine (DENA) induced hepatocellular carcinoma Obaid Afzal, Pavan Goud, Kavita Goyal, Ali Altharawi, Mubarak A. Alamri, Manal A. Alossaimi, Abdulmalik S.A. Altamimi, Surya Nath Pandey Clinica Chimica Acta.2026; 587: 120937. CrossRef
Synthesis, characterization, antioxidant and anticancer potential of Kalanchoe pinnata green synthesized silver nanoparticles targeting p53/MDM2 nexus in hepatic cancer: integrated in vitro and in silico study Afrasim Moin, Talib Hussain, Ahmed Alafnan, Abdulwahab Alamri, Saeed Alghamdi, Syed Mohd.Danish Rizvi, Sirajudheen Anwar, Muskan Chadha, Mohammad Khalid, Rohit Kumar Tiwari, Afza Ahmad Scientific Reports.2026;[Epub] CrossRef
Association of documented social deprivation with cardiovascular and liver outcomes in alcohol-associated liver disease Pojsakorn Danpanichkul, Yanfang Pang, Andrew F. Ibrahim, Supapitch Sirimangklanurak, Allan Bueso, Daniel M. Simadibrata, Shu-Yen Chan, Karn Wijarnpreecha, Mazen Noureddin, Donghee Kim, Suthat Liangpunsakul Alcohol.2026; 132: 24. CrossRef
Efficacy and safety of bronchial arterial infusion chemotherapy combined with transarterial chemoembolization and systemic therapy in hepatocellular carcinoma patients with lung metastases Caihong Yu, Juncheng Wan, Chaoqiao Jin, Changyu Li, Yuqi Jiang, Yongjie Zhou, Xudong Qu International Journal of Cancer.2026; 159(2): 423. CrossRef
ABT-737 efficiently inhibits hepatocellular carcinoma cell activity via regulating PANoptosis Bi Deng, Xuefeng Jin, Dongmei Ye, Hefang Liu, Yunyun Qin, Xiaoyu Chen Discover Oncology.2026;[Epub] CrossRef
Selinexor enhances the sensitivity of hepatocellular carcinoma cells to sorafenib by regulating the BAX/Bcl-2/PUMA apoptotic pathway and the XPO1/p27 cell cycle pathway Shenghong Du, Ling Wang, Chen Chen, Yu Sun, Qian Liu, Jingfei Shi, Feng Zhang, Kai Wang, Chao Cui Frontiers in Oncology.2026;[Epub] CrossRef
Juglans mandshurica-Eleutherococcus senticosus herb pair inhibits hepatocellular carcinoma growth by inducing immunogenic cell death via the HIF-1α/STAT3 pathway Yu Jiang, Lili Jiang, He Zhang, Huiming Lv, Lina Xu, Linlin Zheng, Shengjin Yu Fitoterapia.2026; 190: 107168. CrossRef
Metabolic Concepts of Sodium-Glucose Cotransporter 2 Inhibitors-Based Therapies Against Hepatocarcinogenesis and Therapy Resistance in Hepatocellular Carcinoma Hsien-Hui Chung Life.2026; 16(3): 446. CrossRef
Strategic drug sequencing in hepatocellular carcinoma in the era of chemo-diversity: maximizing the therapeutic benefit of lenvatinib Hideki Iwamoto, Shigeo Shimose, Hironori Koga, Takumi Kawaguchi Journal of Liver Cancer.2026; 26(1): 83. CrossRef
Safety and feasibility of a layered embolization strategy with drug-eluting and uniform-caliber microspheres for advanced hepatocellular carcinoma and unresectable liver metastases: a prospective single-arm clinical trial Xiangrui Chen, Louzong Sun, Min Hu, Ju Zhou, Chengluo Hao, Yunwei Han Frontiers in Oncology.2026;[Epub] CrossRef
Knockdown of CCT2 inhibits the malignant progression of hepatocellular carcinoma cells by impairing STAT3 activation Chao Li, Lei Yang, Yudong Zhang, Baocheng Zhao, Hao Qu Oncology Reports.2026; 55(5): 1. CrossRef
FAT4 loss promotes tumor growth and ferroptosis resistance in hepatocellular carcinoma via PI3K/AKT pathway activation Jing Li, Jialing Sun, Rui Hu, Mengqing Ma, Kongli Fan, Minling Lv, Qi Huang, Wenmin Yang, Yuan Yang, Yan Wang, Xiaozhou Zhou, Xinfeng Sun Clinical and Translational Oncology.2026;[Epub] CrossRef
Moving beyond Ultrasound for Hepatocellular Carcinoma Surveillance in High-Risk Patients with Chronic Hepatitis B Hae Lim Lee Gut and Liver.2026; 20(2): 174. CrossRef
Effects of cirrhosis on 3.0 T MRI DWI features of hepatocellular carcinoma, peri-tumoral sub-zones, and background liver: clinical implications for surgical planning Jinjia Zhu, Yuankai Du, Yidi Hu, Jiachen Jiao European Journal of Radiology.2026; 199: 112791. CrossRef
Case Report: Serum AKR1B10 as a complementary marker for the detection of AFP-negative hepatocellular carcinoma – a report of two cases Ye Gao, Lihua Xie, Yuting Ou, Xi Zeng, Deliang Cao, Jianping Yin Frontiers in Medicine.2026;[Epub] CrossRef
Liver Stiffness Measured by Vibration-Controlled Transient Elastography Predicts Hepatic Decompensation in Patients with Hepatocellular Carcinoma Receiving Systemic Treatments Jaejun Lee, Hyun Yang, Si Hyun Bae, Hee Sun Cho, Pil Soo Sung, Jeong Won Jang, Seung Kew Yoon, Keungmo Yang, Heechul Nam, Chang Wook Kim, Hae Lim Lee, Hee Yeon Kim, Sung Won Lee, Ahlim Lee, Do Seon Song, Seok Hwan Kim, Myung Jun Song, Soon Kyu Lee, Jung H Liver Cancer.2026; : 1. CrossRef
Value of des-gamma-carboxy prothrombin in comprehensive management of hepatocellular carcinoma Zi-Han Liu, Wen-Jun Wang, Shuang-Suo Dang World Chinese Journal of Digestology.2026; 34(2): 110. CrossRef
Characteristics of Patients and Factors Associated With the Development of Hepatitis C Virus‐Associated Hepatocellular Carcinoma in an Urban, Primary‐Care Based Hepatitis C Clinic Kathryn Thompson, James Thompson, Lesley S. Miller Journal of Viral Hepatitis.2026;[Epub] CrossRef
Ginsenosides and gut microbiota: A nutritional strategy for preventing hepatic inflammation-driven carcinogenesis Sitong Lv, Keyu Lu, Yang Yang, Liqiang Wang Journal of Agriculture and Food Research.2026; 27: 102868. CrossRef
Prognostic value of nutritional-inflammatory markers in patients with unresectable hepatocellular carcinoma receiving immune checkpoint inhibitor therapy: a systematic review and meta-analysis Zhihong Chen, Han Zheng, Yunhan Mao, Zhenrong Chen, Peijia He, Yiyao Xu, Xin Lu International Journal of Surgery.2026; 112(3): 8271. CrossRef
Bibliometric analysis of application of radiomics and artificial intelligence integration in personalized treatment of hepatocellular carcinoma Zhujuan Yu, Li Ke, Zhifeng Lin International Journal of Surgery.2026; 112(3): 8095. CrossRef
Unraveling the tapestry: Lessons from multi-omics and spatial biology in hepatocellular cancer Dawiyat Massoudi, Ankit Srivastava, Renumathy Dhanasekaran Hepatology.2026;[Epub] CrossRef
Antibiotic Use Linked to Worse Outcomes in Patients With Gastrointestinal and Liver Cancer on Immune Checkpoint Inhibitors: A Meta-Analysis Mohammad Saeid Rezaee-Zavareh, Hamidreza Karimi-Sari, Peyvand Parhizkar Roudsari, Osama Khattab, Abdelrahman M. Attia, Pojsakorn Danpanichkul, Soo Young Hwang, Jessica S. Liu, Tamar Yalda, Pin-Jung Chen, Jun Gong, Cristina R. Ferrone, Nicole E. Rich, Neeh American Journal of Gastroenterology.2026;[Epub] CrossRef
Evolution of Aptamer Materials Maps Exosomal Surface Proteins at the Nano–Bio Interface Haiyan Cao, Da Xu, Yuming Su, Chenshuo Zhang, Siqi Bian, Xueling Yan, Shaojin Li, Hong Xuan, Jinchen Long, Panzhu Yao, Xiyang Liu, Xuan Cheng, Huang Su, Yifan Chen, Yike Li, Jun Li, Wanlu Shi, Baocai Xing, Kun Wang, Liqin Zhang Nano Letters.2026; 26(13): 4449. CrossRef
Ononin Inhibits the Growth and Metastasis of Hepatocellular Carcinoma by Suppressing MMP‐2 and MMP‐9 via PI3K/AKT/mTOR Signaling Shasha Peng, Jun Guo, Hongfei Fu Journal of Biochemical and Molecular Toxicology.2026;[Epub] CrossRef
Global landscape of yttrium-90 clinical trials: a systematic registry-based analysis Qianwen Ni, Kenan Wang, Wenyi Jin, Yakun Gao, Ping Gong, Zhenguang Wang, Zheqi Xu, Hui Liu, Susu Luo Trials.2026;[Epub] CrossRef
Artificial Intelligence and Radiomics in Primary Liver Cancer Imaging: A Bibliometric and Visualized Analysis Ruizhi Fu, Chen Gao, Xinjing Lou, Ziqing Han, Yizhen He, Chenye Zheng, Zhuping Yu, Hongsheng Chang Journal of Hepatocellular Carcinoma.2026; Volume 13: 1. CrossRef
Prognostic Significance of Intraindividual CT and MRI LI-RADS Agreement and Discordance in Hepatocellular Carcinoma Yong Jun Jung, Seokhwi Kim, In Hye Song, Ju Hyun Shim, Seung Soo Lee, Subin Heo, Sang Hyun Choi Radiology: Imaging Cancer.2026;[Epub] CrossRef
Functional characterization of triokinase/FMN cyclase as a ferroptosis regulator and potential direct target of icaritin in hepatocellular carcinoma Wenpei Guo, Haiyan Yue, Chunan Zhou, Jiefeng He, Lixin Liu International Journal of Biological Macromolecules.2026; 358: 151597. CrossRef
Gadoxetate-enhanced MRI Transitional Phase Parenchymal Signal: Effect on Washout and LI-RADS Diagnostic Performance for Hepatocellular Carcinoma Seong Hyeon Cho, Yong Jun Jung, Seung Baek Hong, Se Jin Choi, Seung Soo Lee, Jae Ho Byun, Hyung Jin Won, Yong Moon Shin, Subin Heo, Sang Hyun Choi Radiology.2026;[Epub] CrossRef
Hepatocellular carcinoma: current aspects of multidisciplinary management. Part 2. Treatment and prevention Yu.M. Stepanov, N.Yu. Zavhorodnia, O.M. Vlasova GASTROENTEROLOGY.2026; 60(1): 52. CrossRef
Bioengineered miR-148a-3p suppresses glycolysis and amino acid homeostasis in hepatocellular carcinoma cells by regulating multiple solute carrier transporters Su Guan, Xin Li, Yimei Wang, Mei-Juan Tu, Ai-Ming Yu Liver Research.2026; 10(2): 166. CrossRef
ADAM15 promotes the progression and metastasis of hepatocellular carcinoma by activating the JNK/p38 pathway Xu Junhui, Su Mengyun Scientific Reports.2026;[Epub] CrossRef
Overcoming immune resistance in hepatocellular carcinoma: insights into mechanisms, predictive factors, and interventional strategies Zhenxao Wang, Jun Wu, Qiao Li, Xin Wen Frontiers in Immunology.2026;[Epub] CrossRef
Characterization and regulatory mechanism evaluation of C8orf33 in hepatocellular carcinoma through multiomics profiling Wei Gao, Siyi Xing, Mingjiang Liu, Xing Xie, Mei Feng, Zhipeng Quan, Housheng Wang, Zhilong He, Qianxin Hu, Huizhao Su, Shuiping Yu, Zeyuan Li Discover Oncology.2026;[Epub] CrossRef
Efficacy and safety of transarterial chemoembolization plus donafenib with or without camrelizumab for unresectable hepatocellular carcinoma: a propensity score matching analysis Qi Zhang, Zhenwu Lei, Hezi Qing, Xingwu Xie Frontiers in Immunology.2026;[Epub] CrossRef
Mechanisms and Management Strategies of Hepatocarcinogenesis Driven by Chronic Hepatitis B Comorbid with Type 2 Diabetes Qin Lou, Jiarong Cai, Jianhua Yin Microorganisms.2026; 14(4): 853. CrossRef
Scientific, regulatory, and practical considerations for bringing hepatocellular carcinoma biomarkers into clinical practice Blanca Botía Martínez-Artero, Eleonora Alimenti, James K. Carter, David J. Pinato, Augusto Villanueva JHEP Reports.2026; 8(8): 101856. CrossRef
G2E3 Suppresses the Tumor‐Killing Function of CD8+ T Cells in Hepatocellular Carcinoma by Boosting CLCN2 Ubiquitination Fan Zhou, Ting Chen, Xingguo Tan, Jun Yu, Mengzhi Xiao, Jun Guo The FASEB Journal.2026;[Epub] CrossRef
Tumor burden score determines survival benefit of anatomic resection in hepatocellular carcinoma: A multicenter propensity-matched study Shujie Pang, Yang Shi, Minjun Jiang, Qingwang Ye, Xin Yan, Zhe Sun, Xingrui Kou, Xiaoxiang Chen, Hui SiMa, Yiming Chen, Yingcheng Yang, Ning Yang European Journal of Surgical Oncology.2026; 52(6): 111850. CrossRef
Advances in the Management of Hepatocellular Carcinoma: Evolving Systemic Therapy, Perioperative Strategies, and Care for Special Populations Jing He, Xiao-Qin Wu, Zhen-Guang Wang Journal of Clinical Question.2026;[Epub] CrossRef
Genome-Scale CRISPR Screens Reveal DNA Repair Dependencies That Sensitize Hepatocellular Carcinoma to Oxaliplatin Hanyue Ouyang, Diyun Huang, Dongsheng Wen, Lichang Huang, Zichao Wu, Zhicheng Lai, Minke He, Wenchao Wu, Ming Shi Cancers.2026; 18(9): 1360. CrossRef
The Antihistamine Astemizole Potentiates the Antitumor Efficacy of Sorafenib in Hepatocellular Carcinoma by Suppressing Proliferation, Metastasis, and Angiogenesis Yixuan Zhang, Xin Chen, Xuting Yang, Peiyu Wang, Xiaoliang Zhang, Dexin Kong, Ran Wang Current Issues in Molecular Biology.2026; 48(5): 451. CrossRef
Liver transplantation is the major determinant of ≥10-year survival in patients with hepatocellular carcinoma Mohammad Saeid Rezaee-Zavareh, Joseph C. Ahn, Hyunseok Kim, Michael Luu, Walid Ayoub, Alexander Kuo, Hirsh Trivedi, Yun Wang, Aarshi Vipani, Tsuyoshi Todo, Georgios Voidonikolas, Justin A. Steggerda, Steven A. Wisel, Todd V. Brennan, Cristina Ferrone, Ire Hepatology Communications.2026;[Epub] CrossRef
First-line therapies for unresectable hepatocellular carcinoma: a network meta-analysis of immune checkpoint inhibitors and transarterial therapies based on 35 randomized trials Huanghui Zhang, Shenyao Zhou, Jiaxin Dai, Hong Huang, Bing Yang, Wenqi Huang, Dongxin Tang Frontiers in Oncology.2026;[Epub] CrossRef
Neutrophil polarization landscapes in HCC: From immunosuppressive niches to antitumor immunity resuscitation Jun Sun, Fan Yang, Yinyan Li, Shenglong Li, Jianbo Song Cancer Letters.2026; 651: 218527. CrossRef
RRP9 suppresses hepatocellular carcinoma progression by inhibiting the PI3K/AKT/mTOR pathway Zhengkang Fu, Man Li, Keshuai Dong, Jiarui Feng, Weixing Wang International Journal of Oncology.2026; 68(6): 1. CrossRef
Liquid-liquid phase separation of TRIM21 regulates EZH2-mediated ferroptosis to facilitate hepatocellular carcinoma progression Li Xu, Shilun Wu, Changyu Yao, Shaohong Wang Cytotechnology.2026;[Epub] CrossRef
Flavokawain A Targets CXCR4‐Mediated Vasculogenic Mimicry to Reverse Hepatocellular Carcinoma Resistance to Tyrosine Kinase Inhibitors Ning Zheng, Yan Chen, Shijie Luo, Jialin Luo, Ayixuwake Bahediyaer, Shizhen Su, Lixian Wu, Jichuang Wang Phytotherapy Research.2026; 40(7): 4206. CrossRef
Mechanisms of Wu Zhuyu Decoction in the treatment of hepatocellular carcinoma: An integrative review of ethnopharmacology, pharmacological actions, and clinical potential Wanni Lu, Jing-Yuan Zhao, Wei Cui, Xin He, Jia-Mei Dong, Ying Zhang, Yuhong Luo, Yihao Sun, Hong Li, Sunlu Jiang, Rui-qi Wang Journal of Ethnopharmacology.2026; 368: 121800. CrossRef
Integrated multi-omics analysis reveals that SMARCAL1 serves as an immune related prognostic marker and promotes liver cancer growth Tingting Huang, Meng Tang, Qiulin Tang, Di Ye, Jiayu Wang, Yichun Duan, Chenliang Zhang, Feng Bi International Journal of Surgery.2026; 112(4): 10192. CrossRef
Self-oxygenating PCN-224(Mn) co-delivers sorafenib and plumbagin to boost chemo-photodynamic therapy in hepatocellular carcinoma Xiang Wang, Hengrui Li, Le Wang, Yihan Ma, Miao Qin, Ruonan Sun, Jing Hu International Journal of Pharmaceutics: X.2026; 11: 100554. CrossRef
Low Tumor Burden Predicts Benefit from Transarterial Treatment in Hepatocellular Carcinoma with Extrahepatic Metastasis: A Nationwide Cohort Study Jaejun Lee, Hyun Yang, Keungmo Yang, Ji Won Han, Pil Soo Sung, Jeong Won Jang, Si Hyun Bae Liver Cancer.2026; : 1. CrossRef
Uncovering Prognostic Biomarkers Underlying Hepatocellular Carcinoma Through Integrative Multi-Omics and a Network-Based Approach Arshad Husain Rahmani, Anam Beg, Tarique Sarwar, Amjad Ali Khan International Journal of Molecular Sciences.2026; 27(10): 4164. CrossRef
Hepatocellular Carcinoma Over Three Decades: from Screening Evolution to Integrated Therapeutic Strategies Ke Huang, Myoung Ok Kim Journal of Cancer Prevention.2026; 31(2): 54. CrossRef
Post-Translational Modification Networks in Ferroptosis: Orchestrating Defense, Drug Resistance, and Therapeutic Opportunities in Hepatocellular Carcinoma Jie Chen, Lingling Li, Sufang Fang, Haitao Zhou Journal of Hepatocellular Carcinoma.2026; Volume 13: 1. CrossRef
Enhancing Capsule on Dynamic Liver CT: Association With Hepatocellular Carcinoma Diagnosis Using LI-RADS Version 2018 Se Jin Choi, Dong Hwan Kim, Sang Hyun Choi, Yong Moon Shin, Jae Ho Byun American Journal of Roentgenology.2026;[Epub] CrossRef
Network Pharmacology and Computational Study to Identify Active Components and Potential Targets of Polygonatum sibiricum for Hepatocellular Carcinoma Treatment Yuan Pan, Xiaoyu Zhang, Chao Chen, Chunmei Hu Combinatorial Chemistry & High Throughput Screening.2026; 29(4): 731. CrossRef
CRISPR Screening in Hepatocellular Carcinoma: From Tumor Progression to Immune Evasion and Therapeutic Resistance Shixin Ma, You Li, Teng Fei International Journal of Molecular Sciences.2026; 27(10): 4241. CrossRef
Recombinant human type-5 adenovirus (H101) combined with radiofrequency ablation versus traditional radiofrequency ablation for hepatocellular carcinoma ≤3 cm: a phase III randomized controlled trial Hai-Su Dai, Zhi-Peng Liu, Hua-Qiang Bi, De-Hong Tan, Yu-Le Luo, Xian-Yu Yin, Yi Gong, Kuan-Sheng Ma, Zhi-Yu Chen, Kai Feng International Journal of Surgery.2026; 112(6): 12827. CrossRef
Comparative Analysis of Deep Learning Approaches for Histopathology-Based Survival Prediction in Hepatocellular Carcinoma Sung Hak Lee, Kwangil Yim, Hyun-Jong Jang Cancers.2026; 18(10): 1534. CrossRef
PD‑1 inhibitors combined with tyrosine kinase inhibitor‑associated hypothyroidism is a predictive factor for antitumor effectiveness in male patients with hepatocellular carcinoma Bailu Cao, Min Ai, Ping Huang, Huan Zhong Oncology Letters.2026; 32(1): 1. CrossRef
PPS03 triggers cancer-selective necroptosis in hepatocellular carcinoma via macropinocytosis-dependent ROS overload Kyung Hwa Choi, Juhee Park, Hyemee Yoon, Keunwan Park, Cheolgoo Hur, Seok-Mo Kim, Ki Cheong Park, Jin Hong Lim Biomaterials.2026; 335: 124323. CrossRef
Hepatocellular Carcinoma in Honduras (2014–2023): Nationwide Trends in Hospital Discharges and Mortality Larissa Acosta Salgado, Daniela Sofia Cruz Betanco, Gisela Pattarone, Zonia Reyes Annals of Hepatology.2026; : 102230. CrossRef
Technical research advances in PET radionuclide tracers for diagnosing hepatocellular carcinoma Yi He, Chunyin Zhang Clinical and Translational Imaging.2026; 14(4): 293. CrossRef
Metabolic Reprogramming Nanoplatform for Broad-Spectrum Lactate Suppression to Reverse High Intensity Focused Ultrasound-Induced Immunosuppression in Hepatocellular Carcinoma Therapy Zeyan Huang, Yi Lin, Rui Tang, Qi Wang, Nianhong Wu, Li Wan, Pan Li, Ju Huang ACS Nano.2026; 20(22): 16036. CrossRef
Multimodal feature fusion with GMM-filtered radiomics for predicting early HCC recurrence Yuting Li, Zhen Wang, Zhenhu He, Chenhong Guo, Jiahao Liu, Zhenwei Peng, Ruhan Liu, Pengfei Rong The Visual Computer.2026;[Epub] CrossRef
Artificial Intelligence in Oncology: A Comprehensive Cross-Cancer Translational Readiness Analysis Across 18 Malignancies Sai Kiran Kuchana, Uday Kumar Repalle, Nikhilesh V. Alahari, Manpreet Kondamuri, Sai Kiran Manduva, Raghu Vamsi Vanguru, Sri Anjali Gorle, Suresh K. Alahari Cancers.2026; 18(10): 1543. CrossRef
Rare Long-Term Transformation from Solitary Hepatocellular Carcinoma to Synchronous Double Primary Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: A Case Report and Literature Review Liyi Qiao, Pengcheng Wei, Chen Lo, Yongjing Luo, Yun Peng, Zhuoliang Kang, Jie Gao, Jiye Zhu, Zhao Li Journal of Hepatocellular Carcinoma.2026; Volume 13: 1. CrossRef
ENPP2 Dysregulation Defines a Candidate Biomarker Axis Coupling Tumor‐Intrinsic cAMP Signaling to Macrophage Polarization in Hepatocellular Carcinoma Shiyi Chen, Jinli Zheng, Jianwu Long, Peng Ou, Jian Tong, Fan Lin, Shaoqiu Chen Human Mutation.2026;[Epub] CrossRef
N-Acetylneuraminate Pyruvate Lyase Promotes Cell Adaptation to Glucose Deprivation by Regulating Intracellular ATP Levels Zhijun Fan, Yi Li, Shuting Geng, Yu Si, Yuerong Yang, Huali Yu, Xue Hu, Jianhai Jiang Current Issues in Molecular Biology.2026; 48(6): 569. CrossRef
Research advances in dual-conversion therapy for hepatocellular carcinoma Jingren Shao, Chuangye Han, Tao Peng Critical Reviews in Oncology/Hematology.2026; 225: 105404. CrossRef
Comparative efficacy and safety of first-line treatments for advanced hepatocellular carcinoma: a Bayesian network meta-analysis Yun Su, Tongze Cai, Jingxuan Wei, Qiuju Huang, Chun Yao, Lei Fu, Jinghui Zheng, Hongwei Guo, Xiongbin Gui Frontiers in Immunology.2026;[Epub] CrossRef
National and regional lifetime risks of developing and dying from digestive system cancers in China: Findings of the Global Burden of Disease Study 2023 Qian Mao, Zhenping Zhao, Jiangmei Liu, Yuchang Zhou, Maigeng Zhou Chinese Medical Journal.2026;[Epub] CrossRef
Diagnostic Accuracy of Extracellular versus Hepatobiliary Contrast-enhanced MRI in LI-RADS Nonradiation Treatment Response Algorithm Version 2024 Subin Heo, Yong Jun Jung, Eun Sun Choi, Sehee Kim, Kyoung Won Kim, Young-In Yoon, Hyung Jin Won, Yong Moon Shin, Dong Hwan Kim, Sang Hyun Choi Radiology.2026;[Epub] CrossRef
Real‐World Evidence on the Efficacy of Icaritin for Unresectable Advanced Hepatocellular Carcinoma: A Multicenter Retrospective Study Dinghu Zhang, Qinfen Xie, Zhewei Zhang, Song Wang, Jibing Liu, Xiang An, Kangshou Liu, Zhengping Yu, Huiling Xiang, Qiang He, Xin Zheng, Zukuan Chang, Ruijie Du, Li Zhang, Gong Li, Qingyu Xu, Wenjie Song, Bin Jin, Chongzhong Liu, Jianjun Li, Xu Zhou, Wenb International Journal of Cancer.2026;[Epub] CrossRef
Comparable Long-Term Survival After Curative Hepatectomy for Solitary Large (5–10 cm) versus Giant (≥10 cm) Hepatocellular Carcinoma: A Retrospective Study Kunyuan Jiang, Jingfei Li, Dongli Zhang, Weiping Wang, Jun Chang Journal of Hepatocellular Carcinoma.2026; Volume 13: 1. CrossRef
Low Tumor miR-369-3p Levels Combined with Plasma Hepatitis B Virus Pre-S2 Gene Deletion Mutation Predict Higher Hepatocellular Carcinoma Recurrence Ya-Chi Wu, Long-Bin Jeng, Tsai-Chung Li, John Wang, Chiao-Fang Teng Journal of Hepatocellular Carcinoma.2026; Volume 13: 1. CrossRef
Trends in MASLD-related cirrhosis and liver cancer across diverse populations, 2010–2023 Jialin Wu, Bonan Chen, Fuda Xie, Jiahui Hu, Mingyu Liang, Yang Lyu, Peiyao Yu, Tiejun Feng, Muyang Huang, Canbin Fang, Ka Fai To, Terry Cheuk-Fung Yip, Xingxin Wang, Wei Kang Hepatology International.2026;[Epub] CrossRef
Development and Validation of a Deep Learning–enabled Single Breath-hold Abbreviated MRI Protocol for Hepatocellular Carcinoma Diagnosis Yunfei Zhang, Zhijun Geng, Xianling Qian, Yuyao Xiao, Ruofan Sheng, Mengsu Zeng Radiology: Artificial Intelligence.2026;[Epub] CrossRef
Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma in the Era of Systemic Therapies (2020–2025) Qi-Feng Chen, Song Chen, Xiongying Jiang, Jiongliang Wang, Ming Zhao Liver Cancer.2026; : 1. CrossRef
Formic acid released by intratumoral Bacteroides thetaiotaomicron facilitates combinational therapy of Apatinib and aPD-1 in hepatocellular carcinoma Jiongjiong Lu, Feiling Feng, Chunlei Li, Ziqing Yu, Tingting Zhang, Anchang Liu, Qingxiang Gao, Zhizhen Li, Li Luo, Xuemei Guan, Yanxiao Xiang, Hao Zhuang Acta Pharmaceutica Sinica B.2026;[Epub] CrossRef
Current advances and future directions in the management of HBV-related hepatocellular carcinoma Andrew F Ibrahim, Julie Sang, Pojsakorn Danpanichkul, Kwanjit Duangsonk, Ju Dong Yang, Thomas A Kerr, Amit G Singal Gastroenterology Report.2026;[Epub] CrossRef
Polyporusterone E, a Key Component of Polyporus umbellatus, as a Potential Regulator of CHEK 1 in Liver Cancer: Integrated Network Pharmacology, Bioinformatics, and Experimental Validation Xinhui Huang, Ruichen Gao, Xinran Yu, Zheng Feng, Qingxia Wang, Xiaotian Wu, Shulu Zhang, Yinze Zhong, Yeqing Xu, Meiting Jiang, Chunli Gan, Xiaotong Wang, Shuang Jiang, Chunjuan Yang International Journal of Molecular Sciences.2026; 27(13): 5694. CrossRef
The Efficiency and Safety of Tace Combined with Targeted Therapy and Immunotherapy for Advanced Hepatocellular Carcinoma Shunyu Kong, Zhenwu Lei, Le Zhang, Jiangang Kang, Wei Cao, Haidong Yu, Jiaxu Wang, Wenyuan Ye, Jingxin Yan Bratislava Medical Journal.2026;[Epub] CrossRef
Lysosome-dependent cell death in hepatocellular carcinoma: unlocking the therapeutic potential of natural products Yijing Xu, Ruixin Wang, Xiaofang Xie, Huali Fan, Fu Peng Frontiers in Pharmacology.2026;[Epub] CrossRef
Natural product FZJDXJ enhances CD8+ T-cell glycolysis to relieve exhaustion and augment antitumor immunity in HBV+ hepatocellular carcinoma Fengna Yan, Yuqing Xie, Ke Shi, Lihua Yu, Qun Zhang, Zhiyun Yang, Xianbo Wang Frontiers in Nutrition.2026;[Epub] CrossRef
Integrating Machine Learning and Single‐Cell Analysis to Reveal the Diagnostic and Therapeutic Value of Regulated Cell Death Mechanisms in Hepatocellular Carcinoma Jiaxing Chen, Zhizhao Yang, Yongqiang Cui, Zhilei Zhao, Xiaobo Wu, Jiaqi Cao, Dongfeng Deng, Miao Yu, Xiulei Zhang, Xiao Zhang The FASEB Journal.2026;[Epub] CrossRef
Insights into the Multifaceted Roles of 3-Mercaptopyruvate Sulfurtransferase in Liver Diseases Yirong Xia, Meng Li Antioxidants & Redox Signaling.2026;[Epub] CrossRef
Regulation of immune tolerance in hepatocellular carcinoma by liver diseases: a review Jinyi Li, Yuanda Liu Infectious Agents and Cancer.2026;[Epub] CrossRef
Near-Infrared Fluorescent Probes Targeting LAG-3 for Guiding Immunomodulation and Efficacy Monitoring of Stereotactic Body Radiotherapy in Liver Cancer Qingyun Lu, Peng Zeng, Yanli An, Yingyu Qin, Jing Zhang, Muhao Xu, Cheng Wang, Ming Wu, Rong Chen Journal of Hepatocellular Carcinoma.2026; Volume 13: 1. CrossRef
Development and Validation of a Machine Learning Model to Prognosticate Hepatocellular Carcinoma Ryan Yanzhe Lim, Vigneshwaran Selvakumar, Nicholas Syn, Gang Chen, Jie Li, Zin Myint Kyaw, Juequn Zhou, Beom Kyung Kim, Karn Wijarnpreecha, Hirokazu Takahashi, Daniel Q. Huang Alimentary Pharmacology & Therapeutics.2026;[Epub] CrossRef
Hinokitiol identified from Phyllanthus fraternus leaves a potential therapeutic solution for hepatocellular carcinoma: a network pharmacology-based study Richa Upadhyay, Pradeep Kumar, Priyanka Yadav, Manoj Kumar Yadav, Kavindra Nath Tiwari In Silico Pharmacology.2026;[Epub] CrossRef
Independent Prognosis Prediction of Hepatocellular Carcinoma Using MicroRNA‐Based Single and Combined Biomarkers Long-Bin Jeng, Wen-Ling Chan, Chiao-Fang Teng, Takaya Shimura Canadian Journal of Gastroenterology and Hepatology.2026;[Epub] CrossRef
Effects of Sevoflurane on the Proliferation, Migration, and Xenograft Growth of HepG2 Hepatocellular Carcinoma Cells: An Exploratory In Vitro and In Vivo Study Kyong Sik Kim, Yeojung Kim, Keuna Shin, Aung Soe Paing, Sujin Baek, Boohwi Hong, Chaeseong Lim Medicina.2026; 62(7): 1267. CrossRef
Uncovering cellular perturbations and key mediator communications in liver cancer using single-cell RNA sequencing Xuchen Ni, Jia Wang, Chao Zhang, Xianming Ge, Mengli Wang, Yan Pan, Sien Ma, Baoying Zheng, Qianqian Chen, Na Xu, Bao Zhao Frontiers in Immunology.2026;[Epub] CrossRef
IGFBP3 As a Potential Biomarker and Therapeutic Target in Hepatocellular Carcinoma: A Multi‐Cohort Analysis Yin Tao, Yunji Xu, Xupeng Chen, Yali Zhou, Jingli Fu Journal of Clinical Laboratory Analysis.2026;[Epub] CrossRef
Single-cell spatial landscape of aggrephagy activity stratifies hepatocellular carcinoma neutrophils and delivers a 5-gene diagnostic panel for patient stratification Wanju Jiang, Kai Wang, Guoshu Li, Qiqi Zhang Translational Oncology.2026; 71: 102893. CrossRef
A Biomimetic Copper‐Caffeic Acid Nanozyme Activates Cuproptosis and Pyroptosis by Mimicking the Neutrophil Enzymatic Cascade Yangyang Lu, Yan Li, Hongyang Yan, Xueying Sun, Xin Li, Yuanyuan Fang, Siyi Zhang, Jingwen Tian, Xin Wang, Cheng Luo, Wensheng Qiu, Weiwei Qi Advanced Healthcare Materials.2026;[Epub] CrossRef
Hypericin Suppresses Liver Cancer Through Autophagic Degradation of AKT and Eliciting Antitumor Immune Response Sien Ma, Qianqian Xu, Mengjuan Zhu, Xianming Ge, Jian Xu, Yan Pan, Mengli Wang, Yuting Zhu, Aoxuan Xu, Hanmeng Liu, GuangHai Xiang, Weipeng Gong, Bao Zhao Cancer Science.2026;[Epub] CrossRef
Interactive Roles of Metabolic Dysfunction‐Associated Steatotic Liver Disease and Nutritional Status in the Prognosis of Patients With Hepatocellular Carcinoma After Surgical Resection Chun‐Ting Ho, Chien‐An Liu, Chia‐Jung Ho, Yi‐Chen Lin, Shin‐Yu Tsai, Hao‐Jan Lei, Shu‐Cheng Chou, Yi‐Hsiang Huang, Ming‐Chih Hou, Jaw‐Ching Wu, Chien‐Wei Su The Kaohsiung Journal of Medical Sciences.2026;[Epub] CrossRef
Virus infections and cancers: from mechanisms to therapeutics Yu Li, Wenjie Yu, Jiaxin Yun, Jingqian Wang, Yakun Liu, Huancheng Su, Hongrui Guo, Jiaolin Yang, Yaru Yan, Xiaoliang Yan, Sanyuan Zhang, Hailan Yang, Zhe Wang Molecular Biomedicine.2026;[Epub] CrossRef
Diagnostic performance of artificial intelligence models in hepatocellular carcinoma: a systematic review and diagnostic meta-analysis Zheng Ren, Jinping Sun, Xiaochun Liu, Yongqiang Li BMC Gastroenterology.2026;[Epub] CrossRef
Antiviral Therapy and Post‐Resection Outcomes in Patients With Hepatitis B Virus‐Related Hepatocellular Carcinoma Jaehong Jeong, Jung Pyo Hong, Dong Yun Kim, Jae Seung Lee, Mi Na Kim, Seung Up Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Hye Won Lee Alimentary Pharmacology & Therapeutics.2026;[Epub] CrossRef
Second-Line and Subsequent Therapies after Atezolizumab Plus Bevacizumab Treatment in Hepatocellular Carcinoma: A Multicenter Prospective Cohort Study Yuri Cho, Jeong-Hoon Lee, Baek-Yeol Ryoo, Ho Yeong Lim, Dong Eun Lee, Bo Hyun Kim, Joong-Won Park Gut and Liver.2026; 20(4): 624. CrossRef
Varices and Hemorrhagic Events during Atezolizumab-bevacizumab Treatment: Reassurance with Caveats for Prognosis Hae Lim Lee Gut and Liver.2026; 20(4): 509. CrossRef
Efficacy and Long-Term Outcomes of Direct-Acting Antivirals in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis Jeong-Ju Yoo, Seul Ki Han, Soon Sun Kim, Hyun Yang, Eunju Kim, Seong Hee Kang, Young Eun Chon, Eileen L. Yoon, Hyun Phil Shin, Sangheun Lee, Do Young Kim, Gi Hyeon Seo, Hyung Joon Kim, Hyun Woong Lee Gut and Liver.2026; 20(4): 665. CrossRef
A Liposomal Nanovaccine Reprograms Post-Ablation Macrophages to Sustain Antitumor Immunity in Hepatocellular Carcinoma Fengkai Qiu, Huilin Hu, Kai Li, Hongkai Qi, Peiyao Liu, Tao Zou, Ping Gong, Qiaoyou Weng, Lin Shen, Liyun Zheng, Shiji Fang, Minjiang Chen, Gaofeng Shu, Jianfei Tu, Jiansong Ji Acta Biomaterialia.2026;[Epub] CrossRef
Hepatocellular Carcinoma in Africa: Epidemiology, Prevention and Outcomes Joseph A Akambase, Ponsiano Ocama, Jose D. Debes Current Hepatology Reports.2026;[Epub] CrossRef
Survival benefits of non‑surgical triple therapy in hepatocellular carcinoma with inferior vena cava/right atrial tumor thrombus: A retrospective analysis from a multidisciplinary team Peng Tang, Jin Li, Jiayu Duan, Xin Wang, Jin Zhou, Yu Yang, Yong Zeng Oncology Letters.2026; 32(3): 1. CrossRef
Predictive value of protein kinase C delta as a diagnostic biomarker for hepatocellular carcinoma in hepatitis C virus-related cirrhosis Heba Amer, A. Elfakhry, El-Hafez Abd, Arman El, Fatma Abozeid Scripta Medica.2026; 57(3): 547. CrossRef
PSMC2 promotes hepatocellular carcinoma progression through interaction with EGFR Yecheng Li, Qunxue Su, Zhenyu Feng, Hui Xu, Tengfei He Clinical and Experimental Medicine.2026;[Epub] CrossRef
Ultrasound technology in hepatocellular carcinoma: Advances in diagnosis, treatment, and prognosis assessment Sheng-Nan Wang, Yu-Xian Li, Tian-Qi Chen World Chinese Journal of Digestology.2026; 34(6): 472. CrossRef
Advances in nanomaterial-enhanced ablation therapy for hepatocellular carcinoma Hao Li, Jiaming Lan, Yusong Qiu, Wendi Kang, Tao Han, Xiupeng Zhang, Zhengqiang Yang, Meng Niu The Innovation Oncology.2026; 1(2): 100029. CrossRef
CR1(+) tumor-associated macrophages orchestrate an immunosuppressive niche in hepatocellular carcinoma: a genetic and multi-omics dissection Zhengjian Wang, Zhe Wang, Xuda Ji, Liping Zhao, Kai Zheng, Wen Yu, Hanzhe Zhang, Hong Chang, Fangfeng Liu Journal of Translational Medicine.2026;[Epub] CrossRef
BRSK2 accumulation mediated by TRIM28 accelerates hepatocellular carcinoma progression via activating the PI3K/AKT/mTOR signaling pathway Shengjin Han, Tan Liang, Cui Yang, Yunlong Xing, Jianzhong Ma, Zhengwu Zhou, Zixiang Chen, Yijun Zhao, Jiangming Chen, Fubao Liu Molecular and Cellular Biochemistry.2026;[Epub] CrossRef
Molecular analysis of genes
MICA
,
GPC3, PNPLA3,
and
TM6SF2
polymorphisms in patients of hepatocellular carcinoma
Wenshuang Zou, Kashif Bashir, Rafia Batool, Maria Nasim, Hafiza Fakhira Ameer, Maryam Ali Nucleosides, Nucleotides & Nucleic Acids.2026; : 1. CrossRef
The PTM Switches of HBx: Master Regulators of HBV Infection and Liver Oncogenesis Zubing Ye, Meijuan Ma, Di Yu, Yibo Hu, Yan Liu, Jun Zhao, Zhanhai Su, Xiaohui Zhao Virus Research.2026; : 199781. CrossRef
Multi-omics and artificial intelligence nominate PCLAF as a prognostic and druggable target for hepatitis B virus-associated hepatocellular carcinoma Feihong Shu, Yidan Chen, Xiaorong Yang, Guoyou Gou, Guonian Li, Jie Yu, Fang Wang, Youjia Liu, Qian Du, Jingyu Xu, Rui Xie Cellular Signalling.2026; 147: 112753. CrossRef
The emerging role of neutrophil extracellular traps in liver diseases: a narrative review Lanbao Ye, Yan Chen, Zefeng Liu, Junfeng Ye, Wengang Chai Medical Molecular Morphology.2026;[Epub] CrossRef
The changing etiology of liver cancer: A comparative study of global and Chinese burden trends from hepatitis dominance to metabolic risks (1990-2021) and forecasts to 2035 Xue Zhou, Mingle Huang, Xiaofen Li, Minjie Zhao, Moushen Tang Liver Research.2026;[Epub] CrossRef
COLEC12high tumor-associated macrophages: A novel paracrine axis driving lenvatinib resistance in hepatocellular carcinoma: Editorial on “COLEC12high tumor-associated macrophages orchestrate lenvatinib resistance and cancer stemness in hepatocellular carc Ji Won Han Clinical and Molecular Hepatology.2026; 32(3): 1463. CrossRef
Discrepancy Between Eligibility and Practice: A 14-Year Nationwide Study on Curative Resection in Elderly Hepatocellular Carcinoma Patients Sun Woong Kim, Jun Sik Yoon, Young Lee, Heejoon Jang Cancers.2026; 18(15): 2457. CrossRef
Evolution of Research on Cell-Specific Magnetic Resonance Imaging Contrast Agents in Hepatocellular Carcinoma: A Bibliometric Study ChenWei Zhang, TianAi Zhang, ShaoZhong Ni Hepatitis Monthly.2026;[Epub] CrossRef
Endoplasmic reticulum stress-related CLIP4 plays a procarcinogenic role in hepatocellular carcinoma: an integrated analysis Anqi Wang, Sitong Yan, Weijia Jiang, Xiang Chen, Yuhan Huang, Xiangyu Zu, Xiao Du, Lulu Fan, Jiatao Liu, Guoping Sun BMC Cancer.2025;[Epub] CrossRef
Progress in the Application of Novel Nanomaterials in Targeted Therapy for Liver Cancer Xin Wei, Weihua Cao, Shiyu Wang, Yaqin Zhang, Zixuan Gao, Shuojie Wang, Linmei Yao, Ziyu Zhang, Xinxin Li, Wen Deng, Yao Xie, Minghui Li International Journal of Nanomedicine.2025; Volume 20: 2623. CrossRef
Rising Incidence of Early-Onset Liver Cancer and Intrahepatic Bile Duct Cancer: Analysis of the National Childhood Cancer Registry Database Pojsakorn Danpanichkul, Yanfang Pang, Thanida Auttapracha, Omar Al Ta’ani, Thanathip Suenghataiphorn, Apichat Kaewdech, Mark D. Muthiah, Donghee Kim, Karn Wijarnpreecha, Amit G. Singal, Ju Dong Yang Cancers.2025; 17(7): 1133. CrossRef
Role of SMYD2 in gastrointestinal cancer progression (Review) Kun Xia, Yaoxiang Zhou, Youping Xie, Yinzhong Cai Oncology Letters.2025; 29(6): 1. CrossRef
Longitudinal study of factors associated with the anti-cancer efficacy and liver function in HCC patients treated with TACE in combination with percutaneous ablation Huhu Ren, Jian Chen, Zhiqun Wu, Chen Li Frontiers in Oncology.2025;[Epub] CrossRef
A Review of Risk Prediction Model for Hepatocellular Carcinoma in Chronic Hepatitis B Jiwon Yang, Mark D. Muthiah, Won-Mook Choi Current Hepatology Reports.2025;[Epub] CrossRef
LPAR6 Inhibits the Progression of Hepatocellular Carcinoma (HCC) by Suppressing the Nuclear Translocation of YAP/TAZ Gegentuya Bao, Manjue Zhai, Yali Yan, Yuewu Wang, Alatangaole Damirin International Journal of Molecular Sciences.2025; 26(9): 4205. CrossRef
PP1A Modulates the Efficacy of Lenvatinib Plus ICIs Therapy by Inhibiting Ferroptosis in Hepatocellular Carcinoma Jitong Zhou, Meng Gao, Shikun Zhang, Wing‐Wa Guo, Wenzhi He, Minghe Zhang, Xi Chen, Cairang Dongzhi, Xiaomian Li, Yufeng Yuan, Weijie Ma Advanced Science.2025;[Epub] CrossRef
Pathogenesis and Treatment of Hepatocellular Carcinoma Associated with Nonalcoholic Steatohepatitis 舒惟 梁 Advances in Clinical Medicine.2025; 15(05): 2063. CrossRef
Engineered E. coli OMVs Carrying the Membrane-Binding hGC33 Fragment Precisely Target Liver Cancer and Effectively Treat Tumor Yufei Deng, Bangya Yang, Zelan Yang, Hanyu Xiao, Yan Zou, Cheng Zou, Song Yang, Xi Sun, Yiting Wang, Jin Bai, Liaoqiong Fang, Zhibiao Wang International Journal of Nanomedicine.2025; Volume 20: 6573. CrossRef
Peripheral blood inflammatory score using a cytokine multiplex assay predicts clinical outcomes in patients treated with atezolizumab-bevacizumab for unresectable HCC Hee Sun Cho, Soon Kyu Lee, Ji Won Han, Jung Hyun Kwon, Soon Woo Nam, Jaejun Lee, Keungmo Yang, Pil Soo Sung, Jeong Won Jang, Seung Kew Yoon, Jong Young Choi Frontiers in Immunology.2025;[Epub] CrossRef
Adding salt to foods and risk of metabolic dysfunction-associated steatotic liver disease and other chronic liver diseases Shunming Zhang, Zhenyu Huo, Yan Borné, Emily Sonestedt, Lu Qi European Journal of Nutrition.2025;[Epub] CrossRef
Targeting super-enhancers in liver cancer: from pathogenic mechanisms to clinical applications Chang-Lei Li, Zhi-Yuan Yao, Ao Sun, Jing-Yu Cao, Zu-Sen Wang Frontiers in Pharmacology.2025;[Epub] CrossRef
Molecular mechanisms underlying Fagopyrum dibotrys-derived nanovesicles induced ferroptosis in hepatocellular carcinoma: a dual-pathway analysis of lipid peroxidation and mitochondrial damage Ling Wu, Hongyao Chen, Jingting Zhang, Jincheng Tang, Zhibin Wang, Peisen Xue, Wenhui Gao, Renyi Yang, Puhua Zeng Frontiers in Pharmacology.2025;[Epub] CrossRef
An Artificial Intelligence Pipeline for Hepatocellular Carcinoma: From Data to Treatment Recommendations Xuebing Zhang, Liuxin Yang, Chengxiang Liu, Xingxing Yuan, Yali Zhang International Journal of General Medicine.2025; Volume 18: 3581. CrossRef
Enhancing ultrasonographic detection of hepatocellular carcinoma with artificial intelligence: current applications, challenges and future directions Janthakan Wongsuwan, Teeravut Tubtawee, Sitang Nirattisaikul, Pojsakorn Danpanichkul, Wisit Cheungpasitporn, Sitthichok Chaichulee, Apichat Kaewdech BMJ Open Gastroenterology.2025; 12(1): e001832. CrossRef
Exploring the impact of sleep duration and sleep disorders on metabolic dysfunction-associated steatotic liver disease in older adults Fan Zhang, Yuan Xue, Wenjian Li BMC Geriatrics.2025;[Epub] CrossRef
Integrating machine learning and molecular docking to decipher the molecular network of aflatoxin B1-induced hepatocellular carcinoma Junjie Gao, Meijun Zhang, Qun Chen, Kai Ye, Jing Wu, Tao Wang, Puhong Zhang, Gang Feng International Journal of Surgery.2025; 111(7): 4539. CrossRef
Managing hepatocellular carcinoma recurrence after liver transplantation: emerging role of immune checkpoint inhibitors Mohammad Saeid Rezaee-Zavareh, Soo Young Hwang, Naomy Kim, Hasmik Adetyan, Nguyen H. Tran, Ju Dong Yang Discover Oncology.2025;[Epub] CrossRef
Addressing Africa's marginalisation in hepatocellular carcinoma clinical trials Mohamed El-Kassas, Hend Shousha, Lewis R Roberts The Lancet Gastroenterology & Hepatology.2025; 10(11): 966. CrossRef
Targeting tumor-associated macrophages to overcome immune checkpoint inhibitor resistance in hepatocellular carcinoma Fen Liu, Xianying Li, Yiming Zhang, Shan Ge, Zhan Shi, Qingbin Liu, Shulong Jiang Journal of Experimental & Clinical Cancer Research.2025;[Epub] CrossRef
Hepatocellular carcinoma of non-viral etiology: From theory to real practice V. V. Petkau, N. E. Krasilnikova, E. N. Bessonova, A. A. Tarkhanov Meditsinskiy sovet = Medical Council.2025; (10): 66. CrossRef
The transcription factor HOXB7 significantly enhances the expression of PIGT through the Wnt/β-catenin signaling pathway, thereby promoting the proliferation and deterioration of HCC Jiaxin Huang, Jiaqi Tan, Nanfeng Meng, Junrong Wang, Peng Han, Hang Wang Expert Review of Anticancer Therapy.2025; 25(11): 1299. CrossRef
A Clinical-Imaging Nomogram for Predicting Early Recurrence in Patients with Solitary Hepatocellular Carcinoma After Postoperative Adjuvant TACE Jiachen Liu, Xiurong Ding, Yanyan Zhang, Hongjun Li Journal of Hepatocellular Carcinoma.2025; Volume 12: 1835. CrossRef
Augmenting conventional criteria: a CT-based deep learning radiomics nomogram for early recurrence risk stratification in hepatocellular carcinoma after liver transplantation Ziqian Wu, Danyang Liu, Siyu Ouyang, Jingyi Hu, Jie Ding, Qiu Guo, Jidong Gao, Jiawen Luo, Ke Ren Insights into Imaging.2025;[Epub] CrossRef
Exploration of the Mechanism of Action of Dendrobium officinale in the Treatment of Liver Cancer Based on Network Pharmacology, Molecular Docking and in vitro Validation Shuimeng Zhan, Xinyan Lu, Hongyan Guo, Yang Liu, Zhi Li, Wei Xu, Fang Xia, Huanjun Tang, Yi Tian, Jing Chen, Xuan Lin Journal of Hepatocellular Carcinoma.2025; Volume 12: 1973. CrossRef
Direct-acting Antivirals Therapy for Hepatocellular Carcinoma in Hepatitis C Patients Seul Ki Han, Soon Koo Baik, Moon Young Kim Journal of Digestive Cancer Research.2025; 13(2): 150. CrossRef
Glypican-3: Novel Theranostic Agent for Hepatocellular Carcinoma Luca Filippi Seminars in Nuclear Medicine.2025; 55(6): 928. CrossRef
Dihydroartemisinin inhibits histone lactylation through YAP1 to act as a ‘hot’ switch for ‘cold’ tumor in hepatocellular carcinoma Yuting Gao, Yi Gong, Xiaoyong Song, Yajun Xiong, Junlan Lu, Yanguang Yang, Yanli Gong, Zhimin Du, Shanshan Wang, Ruilong Jia, Peng Gong, Xinli Shi Phytomedicine.2025; 148: 157307. CrossRef
ANTIFIBROTIC STRATEGY IN THE TREATMENT OF CHRONIC LIVER DISEASES Mariana M. Seliuk, Anatolii M. Pechinka Ukrainian educational and scientific medical space.2025; (1): 28. CrossRef
Selective Angiographic Roadmap Analysis (SARA) of Hepatocellular Carcinoma Feeding Arteries for Transarterial Chemoembolization Sultan R. Alharbi Diagnostics.2025; 15(19): 2533. CrossRef
Binding and ubiquitination-mediated degradation of ACKR3 by the novel Scutellarein derivative TBS6b potently suppresses hepatocellular carcinoma Xing Jiang, Ying Liang, Guotao Tang, Haiyan Quan, Lijun Ruan, Mengli Zhang, Zhijun Song, Min Ou, Zhien Tan, Na Lu, Fangfang Wu, Xiaonan Yang Bioorganic Chemistry.2025; 166: 109073. CrossRef
Role of ALBI Grade as a Predictive Factor for Long‐Term Mortality in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Kyoung A Ko, Hyunwoo Oh, Myung Sub Kim, Hyun Pyo Hong, Yong Kyun Cho, Byung Ik Kim, Won Sohn Journal of Gastroenterology and Hepatology.2025; 40(11): 2758. CrossRef
Innovative Approaches to Hepatocellular Carcinoma: Diagnostic Breakthroughs, Biomarker Integration, and Artificial Intelligence Evangelos Koustas, Eleni-Myrto Trifylli, Panagiotis Sarantis, Michalis V. Karamouzis Biomedicines.2025; 13(10): 2439. CrossRef
Subset of Child-Pugh Score 7 Shows Comparable Survival Outcomes to Child-Pugh Score 6 in Patients with Hepatocellular Carcinoma Treated with Atezolizumab and Bevacizumab Jaejun Lee, Keungmo Yang, Ji Won Han, Pil Soo Sung, Jeong Won Jang, Seung Kew Yoon, Hee Sun Cho, Hyun Yang, Si Hyun Bae, Ji Hoon Kim, Heechul Nam, Chang Wook Kim, Hae Lim Lee, Hee Yeon Kim, Sung Won Lee, Ahlim Lee, Do Seon Song, Myeong Jun Song, Soon Woo Clinical Cancer Research.2025; 31(20): 4323. CrossRef
Plasma exosomal lncRNA-related signatures define molecular subtypes and predict survival and treatment response in hepatocellular carcinoma Fangmin Zhong, Fangyi Yao, Xin-Lu Wang, Zihao Wang, Bo Huang, Jing Liu, Xiaozhong Wang, Lei Zhang Frontiers in Immunology.2025;[Epub] CrossRef
Hepatocellular carcinoma: modern aspects of interdisciplinary management. Part 1. Epidemiology, risk factors, diagnosis Yu.M. Stepanov, N.Yu. Zavhorodnia, O.M. Vlasova GASTROENTEROLOGY.2025; 59(3): 206. CrossRef
Repurposing HIV-Protease Inhibitor Precursors as Anticancer Agents: The Synthetic Molecule RDD-142 Delays Cell Cycle Progression and Induces Autophagy in HepG2 Cells with Enhanced Efficacy via Liposomal Formulation Fabiana Crispo, Antonio Vassallo, Immacolata Faraone, Alessandro Santarsiere, Lucia Chiummiento, Mara Martinelli, Nicoletta Cascelli, Xavier Fernàndez-Busquets, Rocchina Miglionico, Ilaria Nigro, Carla Caddeo, Maria Francesca Armentano International Journal of Molecular Sciences.2025; 26(21): 10305. CrossRef
The multidimensional role of SLC16A4 in hepatocellular carcinoma in silico analysis: prognostic significance, metabolic pathways, and immune microenvironment regulation Lili Jiang, Yi Shen, Zhengyang Feng, Yong Wang, Yaqun Zhu, Yuntian Shen, Qiliang Peng European Journal of Medical Research.2025;[Epub] CrossRef
The potential of soluble programmed cell death-ligand 1 and soluble programmed cell death 1 as diagnostic and prognostic biomarkers for hepatocellular carcinoma: a meta-analysis Jie Li, Xiangyang He, Tingting Gao, Qingjun Zhang, Xu Han Irish Journal of Medical Science (1971 -).2025; 194(6): 2037. CrossRef
Multi-omics analysis reveals the role of tumor-infiltrating CD4+CCR7+ T cells in EGFR antibody resistance and prognosis of hepatocellular carcinoma Zizhong Yang, Lupeng Qiu, Guhe Jia, Zhuoya Sun, Yixin Gong, Yin Chen, Yu Wang, Lai Song, Xiao Zhao, Shunchang Jiao BMC Cancer.2025;[Epub] CrossRef
Identification and validation of icaritin-associated prognostic genes in hepatocellular carcinoma through network pharmacology, bioinformatics analysis, and cellular experiments Yaru Shi, Yanan Bai, Jianglan Wu, Yunfeng Yu, Xinyu Yang, Haobo Yang, Weixiong Jian, Jun Qing Frontiers in Immunology.2025;[Epub] CrossRef
Enhancing cancer risk awareness and screening management through artificial intelligence: a narrative review Jiaxuan Wu, Xiaolong Tang, Qian Zheng, Xinhang Gu, Li Ma, Jinghong Xian, Hui Mao, Jiadi Gan, Guiyi Ji Frontiers in Oncology.2025;[Epub] CrossRef
miR-122-5p Regulates Ferroptosis through Targeting the Glutamine Transporter SLC1A5 in Hepatocellular Carcinoma Mingxuan Lei, Jiayin Xu, Xiaoying Hu, Lin Feng, Baoping Luo BIOCELL.2025; 0: 1. CrossRef
Targeting endoplasmic reticulum stress-induced CLGN resensitizes hepatocellular carcinoma to apoptosis: paeonol synergistically enhances efficacy by dual inhibition of CLGN and NF-κB Sitong Yan, Anqi Wang, Xiang Chen, Weijia Jiang, Xiao Du, Yuhan Huang, Xiangyu Zu, Yue Zhu, Jiatao Liu, Lulu Fan, Lingling Zhang, Guoping Sun Frontiers in Oncology.2025;[Epub] CrossRef
Lactylation in Cancer: Unlocking the Key to Drug Resistance and Therapeutic Breakthroughs Xiangnan Feng, Dayong Li, Pingyu Wang, Xinyu Li, Guangyao Li Oncology Research.2025; 33(11): 3327. CrossRef
Organokine-Mediated Crosstalk: A Systems Biology Perspective on the Pathogenesis of MASLD—A Narrative Review Sandra Maria Barbalho, Lucas Fornari Laurindo, Vitor Engracia Valenti, Nahum Méndez-Sánchez, Mariana M. Ramírez-Mejía, Ricardo de Alvares Goulart International Journal of Molecular Sciences.2025; 26(23): 11547. CrossRef
Systematic analysis of the expression profiles and prognostic values of the FAM72 family in liver cancer Weihao Kong, Long Teng, Kangjie Zhang, Yajun Zou, Xingyu Wang, Jianlin Zhang Biochemistry and Biophysics Reports.2025; 44: 102358. CrossRef
Bioinformatics Analysis Reveals the Role of DLGAP4 in the Development and Progression of Hepatocellular Carcinoma Feng Yang, Shoufeng Chang, Ruxia Li, Jing Wei, Hua Zhang, Qiqi Wang, Zhenjun Li, Yamei Dang Journal of Gastrointestinal Cancer.2025;[Epub] CrossRef
Early screening for liver cancer must be performed Zi-Han Liu, Wen-Jun Wang, Shuang-Suo Dang World Journal of Hepatology.2025;[Epub] CrossRef
–A novel peptide SMIM45-107aa promotes HCC progression via MTDH pathways and its anticancer peptide derivative Yan An, Xiangyang Shi, Wentao Huang, Mingyi Shang, Guang-Zhi Jin Journal of Translational Medicine.2025;[Epub] CrossRef
Liver Transplantation for Hepatocellular Carcinoma: A Comprehensive Review Seok-Hwan Kim Convergence Hepatology.2025; 1(1): 24. CrossRef
Clinical significance of citrullinated glial fibrillary acidic protein in predicting outcomes in hepatocellular carcinoma Yoon Ah Cho, Dong Woo Shin, Mo-Jong Kim, Ji-Won Park, Ji-Young Choe, Jung-Woo Lee, Sung-Hoon Moon, Akihito Ishigami, Eun Kyoung Choi, Sung-Eun Kim World Journal of Gastrointestinal Oncology.2025;[Epub] CrossRef
Prognostic nutritional index and the survival of patients with hepatocellular carcinoma on immune checkpoint inhibitors: a meta-analysis Jia Fu, Wei Peng, Jinqiong Jiang, Tan Deng, Huaxin Duan, Kanghan Liu BMC Cancer.2025;[Epub] CrossRef
Comparative Evaluation of Proprietary and Open-Source Large Language Models for Systematic Multi-source Information Extraction in Interventional Oncology Elif Can, Wibke Uller, Elmar Kotter, Katharina Vogt, Michael Doppler, Michael Brönnimann, Raid Alshinibr, Aboelyazid Elkilany, Felix Busch, Avan Kader, Sebastian Gassenmaier, Saif Afat, Marcus R. Makowski, Keno K. Bressem, Lisa C. Adams CardioVascular and Interventional Radiology.2025; 49(5): 992. CrossRef
Survival benefits of different immunotherapies for hepatocellular carcinoma: a meta-analysis highlighting age, gender, etiology, and tumor burden Ming-Cheng Guan, Na Li, Qian Ding, Di Sun, Hao Li, Mei Yang, Lei Hong, Hong Zhu Frontiers in Immunology.2025;[Epub] CrossRef
Visit‑to‑visit variability of inflammation–immunity indices and prognosis in hepatocellular carcinoma Qiajun Du, Youli Zhao, Jing Yang, Yongxin Yang BMC Gastroenterology.2025;[Epub] CrossRef
Protein induced by vitamin K absence or antagonist II as a prognostic marker in hepatocellular carcinoma patients with normal serum alpha-fetoprotein levels Kuan-Jung Huang, Chun-Ting Ho, Pei-Chang Lee, San-Chi Chen, Chien-An Liu, Shu-Cheng Chou, I-Cheng Lee, Yi-Hsiang Huang, Jiing-Chyuan Luo, Ming-Chih Hou, Jaw-Ching Wu, Chien-Wei Su Journal of the Chinese Medical Association.2025; 88(12): 915. CrossRef
CDCA3 Regulates Tumor-Associated Macrophages Polarize to Promote the Malignant Progression of Hepatocellular Carcinoma Shanmei Lyu, Enqin Wang, Juan Lyu, Hongkun Xu, Daochang Zhang, Zhijun Fang, Lihong Zhang Journal of Hepatocellular Carcinoma.2025; Volume 12: 3029. CrossRef
Combining Transarterial Chemoembolization with Sorafenib Improves Survival in Selected Patients with Hepatocellular Carcinoma and Extrahepatic Spread: A Multicenter Real-World Study Yue Yuan, Yu Qiao, Yejing Zhu, Ping Guo, Jiakun Gou, Kai Liu, Linqian Wang, Shoujie Zhao, Yongchao Zhang, Yunjie Liu, Enxin Wang, Lei Liu Journal of Hepatocellular Carcinoma.2025; Volume 12: 3049. CrossRef
Biomarker-Based Precision Prediction of Immunotherapy Response in Hepatocellular Carcinoma Hsu-Wen Chao, Yi-Mei Joy Lin, Chen-Shiou Wu Diagnostics.2025; 16(1): 85. CrossRef
Emerging DNA- and RNA-based therapeutic strategies in hepatocellular carcinoma: A molecular approach to precision medicine Zulfa Nooreen, Ankita Wal, Anjali Shukla, A. Venkata Badarinath, Nishant Kumar, Tanmay Sarma, Abida Khan, Amin Gasmi Letters in Drug Design & Discovery.2025; 22(11): 100268. CrossRef
Serum Biomarkers for Hepatocellular Carcinoma: A Comparative Review of Traditional and Emerging Markers Min Kyung Park Journal of Digestive Cancer Research.2025; 13(3): 242. CrossRef
Patterns and Prognostic Stratification of Recurrence after Thermal Ablation in Patients with Hepatocellular Carcinoma Chi-Ping Tan, Teng-Yu Lee, I-Cheng Lee, Kuo-Cheng Wu, Chien-An Liu, Nai-Chi Chiu, Shao-Jung Hsu, Pei-Chang Lee, Chi-Jung Wu, Chen-Ta Chi, Jiing-Chyuan Luo, Ming-Chih Hou, Yi-Hsiang Huang Liver Cancer.2025; : 1. CrossRef
Second line therapy after failure of sorafenib continues to be under study. Prognosis of hepatocellular carcinoma is measured in months, with median overall survival reaching 10.7 months with sorafenib. Because of the modest net benefit sorafenib has contributed, and rising incidence of hepatocellular carcinoma in the world, continued efforts are ongoing to look for efficient upfront, second line, or combination therapies. Herein we review the most relevant to date published literature on treatment options beyond sorafenib, reported studies, ongoing investigational efforts, and possibilities for future studies in advanced hepatocellular carcinoma.
Citations
Citations to this article as recorded by
Construction of a multifunctional drug-delivery platform with fluorescence sensing and β-elemene loading for inhibiting the proliferation of hepatocellular carcinoma cells Chaoyu Liu, Xiuhong Pan, Zhen Xiao, Mingyu Qiao, Zhe Tian, Guiyou Wu, Zhongshi Huang, Xiaoying Zhu Journal of Molecular Structure.2026; 1354: 144865. CrossRef
Uncovering the MET-TRIB3-FOXO1 axis: A novel target in MET-driven hepatocellular carcinoma: Editorial on “MET promotes hepatocellular carcinoma development through the promotion of TRIB3-mediated FOXO1 degradation” Ji Eun Han, Soon Sun Kim, Jae Youn Cheong, Jung Woo Eun Clinical and Molecular Hepatology.2026; 32(1): 436. CrossRef
Calculus bovis inhibits liver cancer via the Wnt/β-catenin pathway Jian-Qiang Chen, Xiang Lan World Journal of Gastroenterology.2025;[Epub] CrossRef
Advancements in elucidating the mechanisms of Sorafenib resistance in hepatocellular carcinoma Chen Huang, Yangqian Li, Fengmei Zhang, Chenliang Zhang, Zhenyu Ding International Journal of Surgery.2025; 111(4): 2990. CrossRef
Exploring the enhanced stability and therapeutic efficacy of Sorafenib-Cyclodextrin inclusion complex Snehal K. Shukla, Mimansa Goyal, Dipti D. Kanabar, Seyoum Ayehunie, Bhavesh Deore, Carlos A. Sanhueza, Aaron Muth, Vivek Gupta Journal of Molecular Liquids.2024; 401: 124701. CrossRef
Therapeutic Effects of Natural Products on Liver Cancer and Their Potential Mechanisms Jinhong Guo, Wenjie Yan, Hao Duan, Diandian Wang, Yaxi Zhou, Duo Feng, Yue Zheng, Shiqi Zhou, Gaigai Liu, Xia Qin Nutrients.2024; 16(11): 1642. CrossRef
Construction of a Novel Diagnostic Model Based on Ferroptosis-Related Genes for Hepatocellular Carcinoma Using Machine and Deep Learning Methods Shiming Yi, Chunlei Zhang, Ming Li, Jiafeng Wang, Zhongjie Shi Journal of Oncology.2023; 2023: 1. CrossRef
Knockdown of long non-coding RNA LINC01006 represses the development of hepatocellular carcinoma by modulating the miR-194-5p/CADM1 axis Zhaoxia Sun, Li Zhao, Shuang Wang, Honggang Wang Annals of Hepatology.2022; 27: 100571. CrossRef
Remifentanil reduces the proliferation, migration and invasion of HCC cells via lncRNA NBR2/miR‐650/TIMP3 axis Wei Liang, Jinyuan Ke International Journal of Experimental Pathology.2022; 103(2): 44. CrossRef
Comparison of the outcomes between sorafenib and lenvatinib as the first-line systemic treatment for HBV-associated hepatocellular carcinoma: a propensity score matching analysis Na Ryung Choi, Ju Yeon Kim, Ji Hoon Hong, Moon Haeng Hur, Heejin Cho, Min Kyung Park, Jihye Kim, Yun Bin Lee, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim BMC Gastroenterology.2022;[Epub] CrossRef
The pathogenesis of liver cancer and the therapeutic potential of bioactive substances Song Gao, Xingyue Jiang, Liang Wang, Shanshan Jiang, Hanyuan Luo, Yan Chen, Cheng Peng Frontiers in Pharmacology.2022;[Epub] CrossRef
Potential Therapeutic Strategies to Combat HCC Sidra Altaf, Faiza Saleem, Azam Ali Sher, Ashiq Ali Current Molecular Pharmacology.2022; 15(7): 929. CrossRef
Lenvatinib is independently associated with the reduced risk of progressive disease when compared with sorafenib in patients with advanced hepatocellular carcinoma Soojin Kim, Kyung Hyun Kim, Beom Kyung Kim, Jun Yong Park, Sang Hoon Ahn, Do Young Kim, Seung Up Kim Journal of Gastroenterology and Hepatology.2021; 36(5): 1317. CrossRef
Application of self-assembly peptides targeting the mitochondria as a novel treatment for sorafenib-resistant hepatocellular carcinoma cells Tae Ho Hong, M. T. Jeena, Ok-Hee Kim, Kee-Hwan Kim, Ho Joong Choi, Kyung Hee Lee, Ha-Eun Hong, Ja-Hyoung Ryu, Say-June Kim Scientific Reports.2021;[Epub] CrossRef
Long Non-coding RNA MAFG-AS1 Promotes Cell Proliferation, Migration, and EMT by miR-3196/STRN4 in Drug-Resistant Cells of Liver Cancer Tianming Chen, Bin Huang, Yaozhen Pan Frontiers in Cell and Developmental Biology.2021;[Epub] CrossRef
Validation of Pre-/Post-TACE-Predict Models among Patients with Hepatocellular Carcinoma Receiving Transarterial Chemoembolization David Sooik Kim, Beom Kyung Kim, Jae Seung Lee, Hye Won Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim Cancers.2021; 14(1): 67. CrossRef
Efficacy and Safety of Lenvatinib Therapy for Unresectable Hepatocellular Carcinoma in a Real-World Practice in Korea Myung Ji Goh, Joo Hyun Oh, Yewan Park, Jihye Kim, Wonseok Kang, Dong Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik Liver Cancer.2021; 10(1): 52. CrossRef
Tumor-Stroma Crosstalk Enhances REG3A Expressions that Drive the Progression of Hepatocellular Carcinoma Yuri Cho, Min Ji Park, Koeun Kim, Jae-Young Park, Jihye Kim, Wonjin Kim, Jung-Hwan Yoon International Journal of Molecular Sciences.2020; 21(2): 472. CrossRef
Risk Factors for Liver Function Deterioration after Transarterial Chemoembolization Refractoriness in Child-Pugh Class A Hepatocellular Carcinoma Patients Kang Hyun Park, Jeong Han Kim, Won Hyeok Choe, So Young Kwon, Byung Chul Yoo, Jin Ho Hwang, Sang Woo Park, Young Jun Kim, Hee Sun Park, Mi Hye Yu, Hae Jeong Jeon The Korean Journal of Gastroenterology.2020; 75(3): 147. CrossRef
Formulation, Preparation and Evaluation of Nanostructured Lipid Carrier Containing Naringin and Coix Seed Oil for Anti-Tumor Application Based on “Unification of Medicines and Excipients”
Jiayi Zhu, Yanling Huang, Jiquan Zhang, Yi Feng, Lan Shen Drug Design, Development and Therapy.2020; Volume 14: 1481. CrossRef
EpCAM-high liver cancer stem cells resist natural killer cell–mediated cytotoxicity by upregulating CEACAM1 Dong Jun Park, Pil Soo Sung, Jung-Hee Kim, Gil Won Lee, Jeong Won Jang, Eun Sun Jung, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon Journal for ImmunoTherapy of Cancer.2020; 8(1): e000301. CrossRef
Effectiveness of nivolumab versus regorafenib in hepatocellular carcinoma patients who failed sorafenib treatment Cheol-Hyung Lee, Yun Bin Lee, Minseok Albert Kim, Heejoon Jang, Hyunwoo Oh, Sun Woong Kim, Eun Ju Cho, Kyung-Hun Lee, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Tae-You Kim, Yoon Jun Kim Clinical and Molecular Hepatology.2020; 26(3): 328. CrossRef
Infiltration of T Cells and Programmed Cell Death Ligand 1-expressing Macrophages as a Potential Predictor of Lenvatinib Response in Hepatocellular Carcinoma Pil Soo Sung, Sung Woo Cho, Jaejun Lee, Hyun Yang, Jeong Won Jang, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon Journal of Liver Cancer.2020; 20(2): 128. CrossRef
The disubstituted adamantyl derivative LW1564 inhibits the growth of cancer cells by targeting mitochondrial respiration and reducing hypoxia-inducible factor (HIF)-1α accumulation Inhyub Kim, Minkyoung Kim, Min Kyung Park, Ravi Naik, Jae Hyung Park, Bo-Kyung Kim, Yongseok Choi, Kwan Young Chang, Misun Won, Hyun Seung Ban, Kyeong Lee Experimental & Molecular Medicine.2020; 52(11): 1845. CrossRef
Napabucasin Reduces Cancer Stem Cell Characteristics in Hepatocellular Carcinoma Ya Li, Qiuju Han, Huajun Zhao, Quanjuan Guo, Jian Zhang Frontiers in Pharmacology.2020;[Epub] CrossRef
Control of intracranial disease is associated with improved survival in patients with brain metastasis from hepatocellular carcinoma Hee Chul Nam, Pil Soo Sung, Do Seon Song, Jung Hyun Kwon, Soon Woo Nam, Dong Jin Yoon, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon, Seok Whan Moon, Hong Seok Jang, Jae-Sung Park, Sin-Soo Jeun, Yong-Kil Hong, Si Hyun Bae International Journal of Clinical Oncology.2019; 24(6): 666. CrossRef
Development of a New Nomogram Including Neutrophil-to-Lymphocyte Ratio to Predict Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Young Eun Chon, Hana Park, Hye Kyung Hyun, Yeonjung Ha, Mi Na Kim, Beom Kyung Kim, Joo Ho Lee, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Seong Gyu Hwang, Kwang-Hyub Han, Kyu Sung Rim, Jun Yong Park Cancers.2019; 11(4): 509. CrossRef
Transarterial Chemoembolization in Treatment-Naïve and Recurrent Hepatocellular Carcinoma: A Propensity-Matched Outcome Analysis David Sooik Kim, Tae Seop Lim, Mi Young Jeon, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Oidov Baatarkhuu, Seung Up Kim Digestive Diseases and Sciences.2019; 64(12): 3660. CrossRef
Preclinical efficacy of a novel dual PI3K/mTOR inhibitor, CMG002, alone and in combination with sorafenib in hepatocellular carcinoma Mi Na Kim, Seung Min Lee, Jin Sung Kim, Seong Gyu Hwang Cancer Chemotherapy and Pharmacology.2019; 84(4): 809. CrossRef
Novel Albumin–Bilirubin Grade-Based Risk Prediction Model for Patients with Hepatocellular Carcinoma Undergoing Chemoembolization Jung Hee Kim, Dong Hyun Sinn, Jeong-Hoon Lee, Dongho Hyun, Sung Ki Cho, Sung Wook Shin, Young Chang, Yoon Jun Kim, Jung-Hwan Yoon, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Moon Seok Choi Digestive Diseases and Sciences.2018; 63(4): 1062. CrossRef
RETRACTED: LncRNA NR2F1‐AS1 regulates hepatocellular carcinoma oxaliplatin resistance by targeting ABCC1 via miR‐363 Hai Huang, Jie Chen, Cheng‐Ming Ding, Xin Jin, Ze‐Ming Jia, Jian Peng Journal of Cellular and Molecular Medicine.2018; 22(6): 3238. CrossRef
Natural Killer Cell Dysfunction in Hepatocellular Carcinoma: Pathogenesis and Clinical Implications Pil Soo Sung, Jeong Won Jang International Journal of Molecular Sciences.2018; 19(11): 3648. CrossRef
First
Prev
